Collectively, the results presented indicate that ACF, by inhibiting the transcriptional activity of HIF-1 in normoxia, negatively regulates PDK1 in melanoma cells, which could explain many of the effects observed after ACF treatment (Figure 6). This evidence concerns the gene HIF1A and melanoma.